PERSPECTIVES ON PROPHYLACTIC FACTOR REPLACEMENT FROM ADULT PATIENTS WITH MODERATE AND SEVERE HEMOPHILIA

被引：0
|
作者：
Petrucci, Jessica [1 ]
Floros, Georgina [1 ]
Longmore, Avery [1 ,2 ]
Teitel, Jerome [1 ,2 ]
Sholzberg, Michelle [1 ,2 ,3 ]
机构：
[1] St Michaels Hosp, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Li Ka Shing Knowledge Inst, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2018年 / 93卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E53 / E53
页数：1
相关论文
共 50 条
  • [41] Eradication of factor viii inhibitors in patients with mild and moderate hemophilia A
    Kempton, Christine L.
    Allen, Geoff
    Hord, Jeffrey
    Kruse-Jarres, Rebecca
    Pruthi, Rajiv K.
    Walsh, Christopher
    Young, Guy
    Soucie, J. Michael
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (09) : 933 - 936
  • [42] Factor VIII gene mutations in patients with severe hemophilia A and inhibitors from Venezuela
    Albanez, S.
    de Bosch, N.
    Boadas, A.
    Saez, A.
    Porco, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1118 - 1118
  • [43] Inhibition of fibrinolysis by recombinant factor VIIA in plasma from patients with severe hemophilia A
    Lisman, T
    Mosnier, LO
    Lambert, T
    Mauser-Bunschoten, EP
    Meijers, JCM
    Nieuwenhuis, HK
    de Groot, PG
    BLOOD, 2002, 99 (01) : 175 - 179
  • [44] Factor VIII prophylactic therapy reduces neurological complications in patients with Hemophilia A
    Aragao Fernandes, Jose Marcelino
    Aquino Gondim, Francisco de Assis
    Negreiro Dias, Antonia Maria
    Ribeiro, Rosangela de Albuquerque
    Pires Ferreira Filho, Luiz Ivando
    Teixeira Pinto, Vicente de Paulo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (12) : 1116 - 1122
  • [45] Presence and Evolution of a Catalytic Activity in Patients with Severe, Mild or Moderate Hemophilia A
    Grosbois, Sandrine
    Francois-Brionne, Marie
    Vallee, Elise
    Gautier, Philippe
    Repesse, Yohann
    Borel-Derlon, Annie
    BLOOD, 2011, 118 (21) : 544 - 545
  • [46] Factor VIII haplotypes in severe hemophilia A patients in India
    Patricia Pinto
    Kanjaksha Ghosh
    Shrimati Shetty
    Annals of Hematology, 2013, 92 : 999 - 1000
  • [47] Factor VIII haplotypes in severe hemophilia A patients in India
    Pinto, Patricia
    Ghosh, Kanjaksha
    Shetty, Shrimati
    ANNALS OF HEMATOLOGY, 2013, 92 (07) : 999 - 1000
  • [48] DESIGN OF A REAL-WORLD STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF OMFILOCTOCOG ALFA IN PATIENTS RECEIVING PROPHYLACTIC TREATMENT FOR MODERATE OR SEVERE HEMOPHILIA A
    Yu, S.
    Tang, G.
    Yang, R.
    HAEMOPHILIA, 2022, 28 : 47 - 47
  • [49] Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A
    Collins, P. W.
    Blanchette, V. S.
    Fischer, K.
    Bjorkman, S.
    Oh, M.
    Fritsch, S.
    Schroth, P.
    Spotts, G.
    Astermark, J.
    Ewenstein, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (03) : 413 - 420
  • [50] Prospective cost-effectiveness study of regular continuous prophylactic replacement therapy in adults with severe hemophilia A
    Gringeri, A.
    Monzini, M.
    Von Mackensen, S.
    Muca-Perja, M.
    Borghetti, F.
    Mantovani, L.
    HAEMOPHILIA, 2008, 14 : 135 - 135
12345